4th Circ. Revives Chelsea Therapeutics Class Action

By Ben Conarck (March 16, 2015, 7:19 PM EDT) -- The Fourth Circuit dismantled a North Carolina federal court's ruling that dismissed allegations of misleading investors against Chelsea Therapeutics International Ltd. in a split decision on Monday, saying that the court not only inappropriately relied on regulatory filings to reach its decision, but that it also misinterpreted those documents....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!